Vol 9, No 4 (2002): Folia Cardiologica
Original articles
Published online: 2002-06-21

open access

Page views 454
Article views/downloads 1282
Get Citation

Connect on Social Media

Connect on Social Media

Sekwencyjna metoda oceny rokowania u chorych po przebytym zawale serca

Andrzej Dąbrowski i Elżbieta Kramarz
Folia Cardiol 2002;9(4):303-308.

Abstract

Introduction: Identification of patients at high risk of malignant ventricular arrhythmias and sudden death still remains an unresolved clinical problem. The aim of this study was to investigate the value of a sequential, 2-step procedure in the prediction of arrhythmic events (sustained ventricular tachycardia, ventricular fibrillation and sudden cardiac death) in patients after myocardial infarction.
Material and methods: In the group of 263 postinfarction patients (mean age 60 ± 9 years, 223 men) the standard ECG variables and left ventricular ejection fraction (LVEF) were used as a screening test for predicting arrhythmic events (first stage of sequential procedure). In patients with two or more risk factors (RR interval < 800 ms, QRS complex > 100 ms, QT dispersion ł 100 ms and LVEF < 40%) the analysis of signal averaged ECG and heart rate variability was performed at second stage of sequential procedure. Ventricular late potentials and standard deviation of RR intervals < 70 ms were considered as predictors of arrhythmic events.
Results: During a follow-up period of 36 ± 19 months, the arrhythmic events were noted in 41 (16%) patients. A two-step risk stratification selected a low-risk group of 211 patients with arrhythmic events incidence of 7.6% and a high-risk group of 52 patients with arrhythmic events incidence of 48.1%. Sensitivity, specificity, positive and negative predictive value of sequential procedure for predicting arrhythmic events were, respectively: 61%, 88%, 48% and 92%.
Conclusions: A two-step risk stratification based on standard ECG variables and determination of LVEF at first stage, and heart rate variability and signal-averaged ECG at second stage may be used for selecting patients with an increased risk for arrhythmic events after myocardial infarction.

Article available in PDF format

View PDF Download PDF file